Yukie Kashima

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki, Daichi Yamasoba, Izumi Kimura et al. · Nature · 2022 · 735 citations · Full text

Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Yukie Kashima, Daisuke Shibahara, Ayako Suzuki et al. · Cancer Research · 2021 · 102 citations · Full text

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

Monique B. Nilsson, Yan Yang, Simon Heeke et al. · Cancer Cell · 2023 · 90 citations · Full text

Radiation Oncology, Signaling Pathway, Receptor Tyrosine Kinase +7

Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells

Yumi Fujimoto, Tomoko Morita, Akihiro Ohashi et al. · Scientific Reports · 2020 · 85 citations · Full text

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5

Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda et al. · Communications Biology · 2023 · 60 citations · Full text